CNBX Pharmaceuticals's total assets for Q2 2026 were $14.90K, an increase of 33.48% from the previous quarter. CNBX total liabilities were $2.55M for the fiscal quarter, a -1.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.